Simple blood test could spot deadly bile duct cancers earlier
NCT ID NCT07176962
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study is testing a blood test that looks for DNA changes from tumors to help diagnose and manage biliary tract cancers, which are often found late and have a low survival rate. Researchers will enroll 1,800 participants with confirmed cancers to see how accurate the test is. If it works, it could lead to earlier detection and better monitoring of these aggressive cancers.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- blood test (cell-free DNA methylation liquid biopsy)
- What this could lead to
- If successful, this blood test could help detect biliary tract cancers earlier and monitor them more accurately, potentially improving survival rates.
- What could go wrong
- This is a large but still early-stage study; the test may not be accurate enough in real-world settings, and false positives or negatives could occur.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILLIARY TRACK CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
RECRUITINGShanghai, Shanghai Municipality, 200127, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spirulina's secret protein may shield the liver during surgery
- Can a smart drug home in on Hard-to-Treat GI cancers?
- Can matching drugs to tumor genes beat biliary cancer?
- Can two targeted drugs boost chemo against a rare Bile-Duct cancer?
- New drug cocktail aims to outsmart untreatable bile duct cancer
- Zapping spreading tumors could extend life on current cancer drugs